Browsing by Author Frampton C.M.

Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
2012Betaine and secondary events in an acute coronary syndrome cohortLever M.; George P.M.; Elmslie J.L.; Atkinson W.; Slow S.; Molyneux S.L.; Troughton R.W.; Richards A.M. ; Frampton C.M.; Chambers S.T.
2014Betaine and trimethylamine-N-oxide as predictors of cardiovascular outcomes show different patterns in diabetes mellitus: An observational studyLever M.; George P.M.; Slow S.; Bellamy D.; Young J.M.; Ho M.; McEntyre C.J.; Elmslie J.L.; Atkinson W.; Molyneux S.L.; Troughton R.W.; Frampton C.M.; Richards A.M. ; Chambers S.T.
2014Genetic polymorphism rs6922269 in the MTHFD1L gene is associated with survival and baseline active vitamin B12 levels in post-acute coronary syndromes patientsPalmer B.R.; Slow S.; Ellis K.L.; Pilbrow A.P.; Skelton L.; Frampton C.M.; Palmer S.C.; Troughton R.W.; Yandle T.G.; Doughty R.N.; Whalley G.A.; Lever M.; George P.M.; Chambers S.T.; Ellis C.; Richards A.M. ; Cameron V.A.
2009The common G-866A polymorphism of the UCP2 gene and survival in diabetic patients following myocardial infarctionPalmer B.R.; Devereaux C.L.; Dhamrait S.S.; Mocatta T.J.; Pilbrow A.P.; Frampton C.M.; Skelton L.; Yandle T.G.; Winterbourn C.C.; Mark A.M. ; Montgomery H.E.; Cameron V.A.
2012The contrasting relationships between betaine and homocysteine in two clinical cohorts are associated with plasma lipids and drug treatmentsLever M.; George P.M.; Atkinson W.; Elmslie J.L.; Slow S.; Molyneux S.L.; Troughton R.W.; Richards A.M. ; Frampton C.M.; Chambers S.T.